RecruitingNot ApplicableNCT07144007

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

Van Yuzuncu Yil University Faculty of Medicine Ethics Committee


Sponsor

Yuzuncu Yil University

Enrollment

80 participants

Start Date

Apr 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dexmedetomidine and a drug called Propofol for people with emergence agitation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDexmedetomidine

In rhinoplasty, 10 minute infusion of 0,5 mcg/kg dexmedetomidine will be administered after nasal packing

DRUGPropofol

In rhinoplasty, 0,5 mg/kg propofol IV bolus will be administered after nasal packing


Locations(1)

Van Yüzüncü Yıl University

Van, Tuşba, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07144007


Related Trials